BlackRock, Inc. - 30 Jun 2025 SCHEDULE 13G Report for Xenon Pharmaceuticals Inc. Common Stock (XENE)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Xenon Pharmaceuticals Inc. Common Stock
Symbol: XENE
Shares outstanding: 76,737,242 shares
Disclosed Ownership: 4,757,709 shares
Ownership: 6.2%
Form type: SCHEDULE 13G
Filing time: 17 Jul 2025, 19:44:52 UTC
Date of event: 30 Jun 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	6.2%	4,757,709	4,636,731	0	Spencer Fleming	Managing Director